Digbi Health Expands Telehealth Platform for Enhanced GLP-1 Care
Slice of Healthcare Team
09/26/2024
Key Highlights
- Leverages genetic insights, microbiome analysis, and CGMs to improve GLP-1 medication outcomes.
- Comprehensive GI health screening addresses adherence and effectiveness of GLP-1 drugs.
- Personalized care with GLP-Fit™ and AI-supported nutritional guidance.
- Provides telehealth access for GLP-1 prescriptions and care with both branded and compounded drug options.
- Reduces GI issues in over 90% of patients, improving medication adherence and reducing ER visits.
Source: Business Wire
Notable Quotes
“ At Digbi Health, we leverage the gut microbiome to boost the body’s natural production of GLP-1, enabling patients to taper off medication while maintaining their health and weight loss. ”
Ranjan Sinha, CEO at Digbi Health
“ While GLP-1 drugs are effective, 30% of users gain or lose less than 3% body weight. Digbi Health leverages its expertise in precision biology to improve these outcomes. ”
Dr. Garima Sharma, VP of Care at Digbi Health
